There were only six types of signals observed in CML-CP patients, while 12 and 10 types of signals were found in ALL and CML-BP patients, respectively, suggesting that ALL and CML-BP patients possessed more heterogeneous BCR-ABL1 cloned cells and ACAs. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.